CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion The REVASC Trial From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation

Guideline2013 Oct;34(38):2949-3003.

JOURNAL:Eur Heart J. Article Link

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology

Task Force Members, Montalescot G, Sechtem U et al. Keywords: Angina pectoris; Coronary revascularization; Guidelines; Myocardial ischaemia; Risk factors; Stable coronary artery disease; anti-ischaemic drugs

FULL TEXT PDF